T Cell News and Research

Latest T Cell News and Research

Immunomedics awarded U.S. and Australian patents

Immunomedics announced that it has received notices that the U.S. and Australian patent offices have allowed claims in respective patent applications covering methods for treating a wide range of autoimmune diseases using monoclonal antibodies that bind to the CD22 antigen present on B-lymphocytes.

16 Jun 2005

Cockroach holds secret of women's fertility

The suggestion that a woman’s reproductive history may affect her ability to have children in the future has been a puzzle to scientists for years.

From The University of Manchester 16 Jun 2005

High exposure to the sun halves risk of prostate cancer

Cancer researchers in the U.S. say that high exposure to the sun halved the risk of prostate cancer in men participating in a U.S. trial.

16 Jun 2005

First demonstration of a vaccine for Parkinson's

Researchers at the University of California, San Diego (UCSD) School of Medicine working with scientists at Elan Pharmaceuticals, have reported promising results in mice of a vaccine approach to treating Parkinson’s and similar diseases. These results appear in the June edition of the journal Neuron.

15 Jun 2005

Jumping genes help detemine uniqueness of individual brains

Scientists at the Salk Institute for Biological Studies may have found one explanation for the puzzling variety in brain organization and function: mobile elements, pieces of DNA that can jump from one place in the genome to another, randomly changing the genetic information in single brain cells.

15 Jun 2005

Scientists discover new way of bringing "bio-prospecting" out of the rainforest and into the lab

Nature is a seemingly endless storehouse of interesting - and potentially life-saving - biological molecules. But tracking down and harvesting those chemicals in their natural form can be time-consuming, expensive and unreliable.

15 Jun 2005

Oral liquid Hydroxyurea promising for long-term use in babies with sickle cell disease

Treating babies who have sickle cell disease (SCD) with oral liquid hydroxyurea appears to prevent the onset of long-term complications triggered by this disease, according to results of a preliminary study by investigators at St. Jude Children's Research Hospital.

15 Jun 2005

Fish oil not a good idea for heart defibrillator patients

For heart patients who have surgically implanted defibrillators to shock their weakened hearts back into rhythm, fish oil supplements are not a good idea and in fact appear to do more harm than good.

15 Jun 2005

Exposure to sunlight may decrease the risk of prostate cancer

In the largest such study to date, a research team from three cancer centers measured sunlight exposure in men and found that increased exposure to sunlight may decrease the risk of prostate cancer.

15 Jun 2005

Nanotechnology used to smuggle a powerful chemotherapeutic drug inside tumor cells

University of Michigan scientists have created the nanotechnology equivalent of a Trojan horse to smuggle a powerful chemotherapeutic drug inside tumor cells - increasing the drug's cancer-killing activity and reducing its toxic side effects.

15 Jun 2005

Arteries bio-engineered from elderly cells

Researchers from Duke University's Medical Center and Pratt School of Engineering have demonstrated that they can grow new human blood vessels from cells taken from patients who especially need such assistance – older adults with cardiovascular disease.

14 Jun 2005

Study examines biomarkers for response to erlotinib in glioma

Researchers have found two biomarkers that, in patients with a malignant type of brain tumor called glioblastoma multiforme, were associated with response to the cancer drug erlotinib (Tarceva).

14 Jun 2005

Two common gene variations are associated with the risk for developing chronic kidney disease

Two common gene variations are associated with the risk for developing chronic kidney disease, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions. One variant increases risk and the other decreases risk with a similar effect in whites, African-Americans, diabetic and non-diabetic individuals.

14 Jun 2005

Causes, consequences and clinical implications of alcohol-related brain shrinkage

Previous studies have demonstrated that the brains of alcoholics are smaller, lighter and "shrunken" when compared to nonalcoholic brains.

14 Jun 2005

FDA grants Vical orphan-drug designation

Vical Incorporated today announced that the Office of Orphan Products Development of the U.S. Food and Drug Administration (FDA) has designated the company's bivalent (two-plasmid) formulation of the company's vaccine against cytomegalovirus (CMV) as an orphan drug for the prevention of clinically significant CMV viremia, CMV disease and associated complications in at-risk hematopoietic cell transplant (HCT) and solid organ transplant (SOT) populations.

14 Jun 2005

US scientists find "mother of all brain stem cells"

Scientists at the University of Florida have been able grow brain cells in the laboratory.

14 Jun 2005

Anti-cancer drug may help prevent premature births

A team from University of Newcastle upon Tyne in the UK have found that the anti-cancer drug Trichostatin A (TSA), has the potential to control early labour contractions. They are optimistic the work, which is still in the early stages, will help to reduce the 70,000 premature births in the UK each year.

14 Jun 2005

CalbaTech subsidiary files patent for stem cell delivery device

CalbaTech announced today that its wholly owned subsidiary, LifeStem has filed a U.S. Patent Application for its Stem Cell Delivery Device. The patent is for the Device and Methods for Treatment of Necrotic Tissue using Stem Cells.

14 Jun 2005

People who smoke or are obese are biologically older than slim individuals and non-smokers

Obesity and smoking are important risk factors for many age-related diseases. Tim Spector (St. Thomas’ Hospital, UK) and colleagues in the USA looked for evidence of ageing at a molecular level in smokers and obese individuals.

13 Jun 2005

Chemotherapy for brain tumors is boosted after vaccine targets resistance-related TRP-2 antigen

In the August issue of the journal Oncogene, researchers at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute describe a molecular mechanism that appears to make malignant brain tumors more vulnerable to chemotherapy after they have been treated with the dendritic cell vaccine.

13 Jun 2005